Business Standard

Covid-19: India's flimsy antigen testing regime 'like flipping a coin'

Between 25-30 per cent of the country's daily tests now are rapid antigen tests, Balram Bhargava, the director-general of the Indian Council of Medical Research, told reporters

Coronavirus
Premium

A health worker wearing personal protective equipment collects a swab sample from a resident at a Covid-19 testing site in the courtyard of a school in New Delhi.

Ragini Saxena | Bloomberg
India’s bid to control its surging virus infections by increasing the use of fast but less sensitive tests could actually be making things worse for the nation.

With one of the world’s fastest-growing epidemics but also one of the lowest testing rates, India in late June started to use quick antigen tests to ramp up detection. But the tests, which can report false negatives as much 50 per cent of the time, threaten to obscure the true picture of its outbreak, further challenging containment efforts.

Between 25-30 per cent of the country’s daily tests now are rapid antigen tests, Balram

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in